Charlotte’s Web Holdings (TSE:CWEB) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Charlotte’s Web Holdings shares promising Phase 1 trial results for AJA001, a botanical drug developed for autism spectrum disorder, showcasing its safety and potential efficacy. The trial leverages a proprietary hemp extract, underscoring the company’s commitment to innovative therapies for underserved conditions.
For further insights into TSE:CWEB stock, check out TipRanks’ Stock Analysis page.